Back to calendar
Corvus Pharmaceuticals, Inc. (CRVS) Earnings
CRVS reports earnings on Tuesday, August 11, 2026
earnings report
August 11, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.16
Actual EPS: $-0.15
EPS surprise: -5.32%
Company overview
Market Cap$1.3B
PriceUSD 14.97
EPS (TTM)-0.53
52-week high26.95
52-week low3.96
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees37